Global Amyotrophic Lateral Sclerosis Market Size & Trends Report Segmented by Treatment (Medication, Stem Cell Therapy, Others), Treatment Type (Sporadic, Familial), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Others) & Regional Forecasts to 2029

Request Quote Download FREE Sample
Single User

Table of Contents

  • Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
      • Research Timeframe
      • Currency Considered
      • Study Limitations
      • Stakeholders
      • List of Abbreviations
      • Key Conferences and Events (2023-2024)
    • Research Methodology
      • Secondary Research
      • Primary Research
      • Market Estimation
        • Bottom-Up Approach
        • Top-Down Approach
      • Market Forecasting
    • Executive Summary
      • Amyotrophic Lateral Sclerosis Market Snapshot (2023-2029)
      • Segment Overview
      • Regional Snapshot
      • Competitive Insights
    • Market Overview
      • Market Dynamics
        • Drivers
          • Increasing prevalence of ALS globally
          • Advancements in biotechnology
          • Growing investments in ALS research and drug development
        • Restraints
          • Lack of clear understanding of ALS pathogenesis
          • High costs of drug development and clinical trials
          • Limited number of approved therapies
        • Opportunities
          • Development of disease-modifying therapies
          • Adoption of telemedicine and remote monitoring for ALS patient management
        • Key Market Trends
          • Increasing focus on gene-editing and gene-based therapies
          • Adoption of advanced rehabilitation and respiratory support technologies
      • Unmet Market Needs
      • Industry Speaks
      • Regulatory Analysis
    • Global Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), By Treatment, USD Million
      • Introduction
      • Medication
        • Riluzole
        • Edaravone
        • Others
      • Global Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), By Type, USD Million
        • Introduction
        • Sporadic ALS
        • Familial ALS
      • Global Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), By Distribution Channel, USD Million
        • Introduction
        • Hospitals Pharmacies
        • Retail Pharmacies
        • Others
      • Global Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), By Region, USD Million
        • Introduction
        • North America Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), By Country, USD Million
          • US
            • Market Size & Forecast, By Treatment (USD Million)
            • Market Size & Forecast, By Type (USD Million)
            • Market S)
          • Canada
            • Market Size & Forecast, By Treatment (USD Million)
            • Market Size & Forecast, By Type (USD Million)
            • Market Size & Forecast, By Distribution Channel (USD Million)
        • Europe Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), By Country, USD Million
          • UK
            • Market Size & Forecast, By Treatment (USD Million)
            • Market Size & Forecast, By Type (USD Million)
            • Market Size & Forecast, By Distribution Channel (USD Million)
                • Germany
                  • Market Size & Forecast, By Treatment (USD Million)
                  • Market Size & Forecast, By Type (USD Million)
                  • Market Size & Forecast, By Distribution Channel (USD Million)
                • France
                  • Market Size & Forecast, By Treatment (USD Million)
                  • Market Size & Forecast, By Type (USD Million)
                  • Market Size & Forecast, By Distribution Channel (USD Million)
                • Italy
                  • Market Size & Forecast, By Treatment (USD Million)
                  • Market Size & Forecast, By Type (USD Million)
                  • Market Size & Forecast, By Distribution Channel (USD Million)
                • Spain
                  • Market Size & Forecast, By Treatment (USD Million)
                  • Market Size & Forecast, By Type (USD Million)
                  • Market Size & Forecast, By Distribution Channel (USD Market Size & Forecast, By Type (USD Million)
                  • Market Size & Forecast, By Distribution Channel (USD Million)
              • Asia Pacific (APAC) Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), By Country, USD Million
                • China
                  • Market Size & Forecast, By Treatment (USD Million)
                  • Market Size & Forecast, By Type (USD Million)
                  • Market Size & Forecast, By Distribution Channel (USD Million)
                • Japan
                  • Market Size & Forecast, By Treatment (USD Million)
                  • Market Size & Forecast, By Type (USD Million)
                  • Market Size & Forecast, By Distribution Channel (USD Million)
                • India
                  • Market Size & Forecast, By Treatment (USD Million)
                  • Market Size & Forecast, By Type (USD Million)
                  • Market Size & Forecas Forecast, By Treatment (USD Million)
                  • Market Size & Forecast, By Type (USD Million)
                  • Market Size & Forecast, By Distribution Channel (USD Million)
              • Latin America (LATAM) Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), USD Million
                • Market Size & Forecast, By Treatment (USD Million)
                • Market Size & Forecast, By Type (USD Million)
                • Market Size & Forecast, By Distribution Channel (USD Million)
              • Middle East & Africa (MEA) Amyotrophic Lateral Sclerosis Market Size & Forecast (2022-2029), USD Million
                • Market Size & Forecast, By Treatment (USD Million)
                • Market Size & Forecast, By Type (USD Million
                • Market Size & Forecast, By Distribution Channel (USD Million)
            • Competitive Landscape
              • Key Players andise Player Mapping
              • Market Share Analysis (2023)
              • Company Categorization Matrix
                • Dominants/Leaders
                • New Entrants
                • Emerging Players
                • Innovative Players
            • Key Strategies Assessment, By Player (2022-2024)
              • New Product Launches
              • Partnerships, Agreements, & Collaborations
              • Mergers & Acquisitions
              • Geographic Expansion
          • Company Profiles* (Business Overview, Financial Performance**, Products Offered, Recent Developments)
            • Amylyx Pharmaceuticals, Inc.
            • Biogen
            • BrainStorm Cell Limited
            • Ionis Pharmaceuticals, Inc.
            • Mitsubishi Tanabe Pharma Corporation
            • Sanofi
            • Otsuka Pharmaceutical Co., Ltd.
            • Hoffmann-La Roche Ltd
            • AB Science
            • Sun Pharmaceutical Industries Ltd.
            • Orion Corporation
            • Other Prominent Players

          Note: *Indicative list

          **For listed companies</